Epstein-Barr virus infection following allogeneic hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis. (PubMed, Exp Hematol Oncol) - May 15, 2025 - "Our findings emphasized that although letermovir prophylaxis did not increase the risk of EBV DNAemia in allo-HCT recipients, it was associated with a higher incidence of PTLD. Further studies focusing on immune reconstitutiom dynamics are warranted to elucidate the underlying pathophysiology of EBV-PTLD under letermovir pressure."
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Infectious Disease • Transplantation • CD8
|
|
Chuanhe Jiang; Jiayu Huang; Jing Zhou; Jingtao Huang; Luxiang Wang; Ruoxuan Zhang; Shixuan Zhang; Xiaoxia Hu; Yang Cao; Yanmin Zhao; Zengkai Pan; Zilu Zhang
|